Amanta Healthcare, a pharmaceutical company engaged in sterile liquid product manufacturing, plans to raise ₹126 crore through g. The shares will be listed on the main board of NSE and BSE.
The company will issue one crore equity shares in the price range of ₹120-₹126 per equity shares.
The net proceeds from the IPO will be used to fund capital expenditure for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Kheda in .
The company will also invest in new manufacturing line for SVP at Kheda, Gujarat.
Timeline
The anchor portion will open on Friday and the issue will close on September 3.
Beeline Capital Advisors will be the lead Manager to the Issue while MUFG Intime India has been appointed as registrar.
Bhavesh Patel, Chairman and Managing Director, Amanta Healthcare said the company has grown by developing and supplying a wide range of sterile liquid products across therapeutic segments and medical devices both across domestic and international markets.
The IPO will facilitate the company to expand manufacturing capabilities with new SteriPort and SVP lines at Hariyala facility besides supporting future plans.
Financials
In FY25, the company achieved a revenue of ₹275 crore, EBITDA of ₹61 crore and net profit of ₹10 crore.